Literature DB >> 2131796

Endoscopic transthoracic electrocautery of the sympathetic chain for palmar and axillary hyperhidrosis.

J Byrne1, T N Walsh, W P Hederman.   

Abstract

Endoscopic transthoracic electrocautery of the sympathetic chain has been the preferred treatment for palmar or axillary hyperhidrosis in this unit since 1980. A retrospective study was carried out of the first 112 patients with case material derived from a postal questionnaire, chart review and outpatient assessment. Eighty-five patients undergoing bilateral transthoracic electrocautery who replied to the questionnaire (76 per cent response rate) form the basis of this study. There were 65 females and 20 males with a mean age of 24.3 years (range 15-40 years). The hands alone were affected in 20 patients (24 per cent), the axillae alone in 17 (20 per cent) and both areas in 48 (56 per cent). Mean hospital stay was 3.1 days (range 1-7 days). Outcome was assessed by 92 per cent of patients immediately after operation as 'very much improved' or 'moderately improved', and this assessment persisted in 85 per cent after a mean follow-up of 43 months (range 3-95 months). Cosmetic results were rated as satisfactory by 95 per cent. Apart from pain after operation, morbidity was limited to transient Horner's syndrome in three patients, surgical emphysema in three, and pneumothorax requiring a chest drain in one. A repeat procedure was needed in one patient because of an inadequate first operation. Some compensatory hyperhidrosis occurred in 54 (64 per cent) patients. As a minimally invasive procedure, endoscopic transthoracic electrocautery should be considered the treatment of choice for palmar and axillary hyperhidrosis.

Entities:  

Mesh:

Year:  1990        PMID: 2131796     DOI: 10.1002/bjs.1800770931

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  36 in total

1.  Thoracic origin of a sympathetic supply to the upper limb: the 'nerve of Kuntz' revisited.

Authors:  L Ramsaroop; P Partab; B Singh; K S Satyapal
Journal:  J Anat       Date:  2001-12       Impact factor: 2.610

Review 2.  Thoracoscopic sympathectomy for palmar hyperhidrosis. Ablate or resect?

Authors:  M Hashmonai; A Assalia; D Kopelman
Journal:  Surg Endosc       Date:  2001-04-03       Impact factor: 4.584

3.  Thoracoscopic dissection of the esophagus: an experimental study.

Authors:  D Gossot; M D Ghnassia; H Debiolles; Y Chourrout; J M Bonnichon; E Sarfati; M Celerier; Y Revillon
Journal:  Surg Endosc       Date:  1992 Mar-Apr       Impact factor: 4.584

4.  Improving oesophageal access through thoracoscopy.

Authors:  O J McAnena
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

5.  Infraareolar access for thoracoscopic sympathectomy to treat primary hyperhidrosis.

Authors:  Sônia Oliveira Lima; Yasmin Gama Abuawad; Paulo Sérgio Faro Santos; Aloisio Ferreira Pinto Neto; Vanessa Rocha de Santana; Francisco Prado Reis
Journal:  Surg Today       Date:  2012-06-06       Impact factor: 2.549

6.  Anatomical variations of the second thoracic ganglion.

Authors:  B Singh; L Ramsaroop; P Partab; J Moodley; K S Satyapal
Journal:  Surg Radiol Anat       Date:  2005-03-31       Impact factor: 1.246

Review 7.  Hyperhidrosis--causes and treatment of enhanced sweating.

Authors:  Tanja Schlereth; Marianne Dieterich; Frank Birklein
Journal:  Dtsch Arztebl Int       Date:  2009-01-16       Impact factor: 5.594

8.  Morphometric study of the upper thoracic sympathetic Ganglia.

Authors:  Sang Beom Lee; Jae Chil Chang; Sukh Que Park; Sung Jin Cho; Soon Kwan Choi; Hack Gun Bae
Journal:  J Korean Neurosurg Soc       Date:  2011-07-31

9.  Endoscopic transthoracic sympathectomy in the treatment of hyperhidrosis.

Authors:  R A Edmondson; A K Banerjee; J A Rennie
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

10.  Long-term results of a randomized controlled trial of T2 versus T2-T3 ablation in endoscopic thoracic sympathectomy for palmar hyperhidrosis.

Authors:  Wilson Ong; Alvin Lee; Wee Boon Tan; Davide Lomanto
Journal:  Surg Endosc       Date:  2015-07-07       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.